Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9701
-0.0038 (-0.39%)
At close: Sep 26, 2025, 4:00 PM EDT
0.9800
+0.0099 (1.02%)
After-hours: Sep 26, 2025, 7:01 PM EDT
OTLK's stock price has decreased by -82.43% in the past year and price targets may not have had time to catch up.
Outlook Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$5.25
Upside
+441.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $21 → $8 | Strong Buy | Maintains | $21 → $8 | +724.66% | Sep 22, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $1 | Strong Buy → Hold | Downgrades | $1 | +3.08% | Aug 29, 2025 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 | Hold | Maintains | $3 | +209.25% | Aug 28, 2025 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 | Hold | Maintains | $3 | +209.25% | Aug 15, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $24 → $21 | Strong Buy | Maintains | $24 → $21 | +2,064.73% | Jun 6, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $33 → $24 | Strong Buy | Maintains | $33 → $24 | +2,373.97% | Feb 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $3 | Strong Buy | Maintains | $30 → $3 | +209.25% | Feb 18, 2025 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 | Hold | Maintains | $3 | +209.25% | Feb 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +1,136.99% | Jan 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +2,992.46% | Jan 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 2, 2024 |
| BTIG | BTIG | Strong Buy Maintains $50 → $9 | Strong Buy | Maintains | $50 → $9 | +827.74% | Nov 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +2,992.46% | Nov 29, 2024 |
| BTIG | BTIG | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +5,054.11% | Oct 18, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $35 → $33 | Strong Buy | Maintains | $35 → $33 | +3,301.71% | Sep 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.